The following is a selection of recent fact sheets and policy guidance documents produced by IAVI in partnership with key stakeholders. These include:
To access archived IAVI fact sheets and publications, please click here.
For global statistics on HIV/AIDS, tuberculosis, and infectious diseases, please visit the WHO and UNAIDS websites.
IAVI Fact Sheets
An overview of the progress IAVI and partners made in 2018 toward our pursuit to translate scientific discoveries into affordable, globally accessible public health solutions.
A vaccine is the world’s best hope to end AIDS. Despite impressive progress in delivering HIV treatment, ending the AIDS pandemic will require new approaches to prevent HIV infection. An effective vaccine would dramatically reduce HIV infections and deaths globally. Without a vaccine, we may actually see increases in infection rates.
An effective HIV vaccine will help to end the AIDS epidemic in the U.S. while reducing the cost of treatment programs domestically and overseas.
The only way to end HIV/AIDS as a public health problem of global importance is with a vaccine. IAVI remains committed to developing a safe, effective, globally useful one.
The IAVI Vaccine Design and Development Lab generates and develops innovative HIV and emerging infectious diseases vaccine candidates to address global public health needs.
IAVI is applying its vaccine development expertise and working with a group of expert international partners to develop vaccines to prevent emerging infectious diseases.
Policy & Advocacy Publications
IAVI served on the the technical working group for the Health Research and Innovation Strategy for Africa HRISA developed by the African Union Development Agency. The objective of the document is to facilitate coordinated, sustainable, and responsive health research and innovation that will provide effective interventions for health in Africa.
Developed by the East Africa Health Research Commission with support from IAVI, this document outlines strategies to help close the domestic health financing gap in Burundi, Kenya, Rwanda, Uganda, and Tanzania.
These guidelines have been developed to operationalize the plan specific to key populations identified in Kenya’s Fast Track Plan, namely young women who sell sex, young men who have sex with men, and young people who inject drugs. This document defines these three populations by their HIV risk and vulnerability and identifies optimal strategies that will prevent new infections among the populations.
As part of the East Africa Health Research Commission, IAVI advocates for the alignment of research ethics committees across East Africa to accelerate and enhance the region's scientific research outputs.
A protocol to provide guidance on responding to and preventing violence against key populations in Kenya, and to increase their access to HIV prevention and care services. This guidance document was developed by IAVI in partnership with the National AIDS Control Council and the National AIDS and STI Control Project, Ministry of Health, Kenya.
Best practices guidance in conducting HIV research with gay, bisexual, and other men who have sex with men (MSM) in rights-constrained environments.
Community Engagement Resources